Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase III Double-Blind Randomized Crossover Study of Plerixafor Versus G-CSF in the Treatment of Patients With WHIM Syndrome.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02231879
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:13.698342+00:00
Published At
2023-04-07T00:00:00+00:00
Record Updated At
2023-04-07
Results Posted At
2023-04-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Myelokathexis", "Infections", "Neutropenia", "Warts", "Hypogammaglobulinemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-04-07"
protocolSection.identificationModule.nctId
"NCT02231879"
protocolSection.identificationModule.officialTitle
"A Phase III Double-Blind Randomized Crossover Study of Plerixafor Versus G-CSF in the Treatment of Patients With WHIM Syndrome."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-04-07"

Study condition terms

  • Myelokathexis (protocolSection.conditionsModule.conditions)
  • Infections (protocolSection.conditionsModule.conditions)
  • Neutropenia (protocolSection.conditionsModule.conditions)
  • Warts (protocolSection.conditionsModule.conditions)
  • Hypogammaglobulinemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.